Polymorphisms in SLC6A4, PAH, GABRB3, and MAOB and modification of psychotic disorder features

Sarah E. Bergen, Ayman H. Fanous, Dermot Walsh, F. Anthony O'Neill, Kenneth S. Kendler

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Abstract

We tested four genes [phenylalanine hydroxylase (PAH), the serotonin transporter (SLC6A4), monoamine oxidase B (MAOB), and the gamma-aminobutyric acid A receptor β-3 subunit (GABRB3)] for their impact on five schizophrenia symptom factors: delusions, hallucinations, mania, depression, and negative symptoms. In a 90 family subset of the Irish Study of High Density Schizophrenia Families, the PAH 232 bp microsatellite allele demonstrated significant association with the delusions factor using both QTDT (F = 8.0, p = .031) and QPDTPHASE (chi-square = 12.54, p = .028). Also, a significant association between the GABRB3 191 bp allele and the hallucinations factor was detected using QPDTPHASE (chi-square = 15.51, p = .030), but not QTDT (chi-square = 2.07, p = .560).

Original languageEnglish (US)
Pages (from-to)94-97
Number of pages4
JournalSchizophrenia Research
Volume109
Issue number1-3
DOIs
StatePublished - Apr 2009
Externally publishedYes

Keywords

  • GABRB3
  • MAOB
  • PAH
  • SERT
  • SLC6A4
  • association
  • modifier
  • schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Fingerprint

Dive into the research topics of 'Polymorphisms in SLC6A4, PAH, GABRB3, and MAOB and modification of psychotic disorder features'. Together they form a unique fingerprint.

Cite this